Madrigal Pharmaceuticals, Inc. - MDGL Choraklik daromad o'sishi

Madrigal Pharmaceuticals, Inc. (MDGL) - korporativ logo

Madrigal Pharmaceuticals (MDGL) Rezdiffra tufayli NASH nishasida monopoliya huquqiga ega bo'lib, bu faqat sinovlar va yetkazib berishlarni buzishi mumkin bo'lgan geosiyosiy xatarlar bilan cheklangan. GURU.Markets terminalidan olingan ushbu grafik choraklik daromadning foizdagi o'sishini aks ettiradi, bunda 50.40 ushbu ko'rsatkichning joriy qiymatini ifodalaydi. Biznes aktivlarsiz modelga tayanadi va dori ishlab chiqarishni uchinchi tomon zavodlariga autsorsing qiladi, bu esa kompaniyaning barqarorligini tashqi pudratchilarga bog'liq qiladi.

MDGL Madrigal Pharma Choraklik sotuv ortish sur'ati (04.07.2022 - 20.11.2026)

MDGL (Madrigal Pharmaceuticals, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy kotirovkalar va o'rtacha qiymat prognozi:
- pul mablag'lari va pul oqimlari ko'rsatkichlari:
Kompaniyaning barcha koʻrsatkichlari tahlili:Madrigal Pharmaceuticals, Inc. (MDGL)
madrigalpharma.com seriyali mahsuloti

Madrigal Pharmaceuticals (MDGL) uchun savdo momentumining dinamikasi birinchi ixtisoslashtirilgan dori vositasining bozorga chiqarilish muvaffaqiyatini belgilaydi. Ushbu ko'rsatkich tijorat kengayishining tezligini o'lchash uchun joriy chorakdagi daromadning oldingi chorakka nisbatan foizdagi o'zgarishi sifatida hisoblanadi. Choraklik daromadlar dinamikasini tahlil qilish orqali investor dori vositasining tibbiy amaliyotga integratsiyalashuv samaradorligini baholaydi. Ma'lumotlarning yuqori tebranishlari pul oqimining shakllanish bosqichini va emitentning umumiy moliyaviy noaniqligini aks ettiradi.

Toʻgʻridan-toʻgʻri raqobatchilar

ASND - Daromadning choraklik o'sishi (QoQ)|CORT: Daromadning choraklik o'sishi (QoQ)|RYTM: Choraklik daromad o'sishi|AKRO - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) Metsera Therapeutics|MoonLake Corp (MLTX) - Choraklik sotuv ortish sur'ati|Daromadning choraklik o'sishi (QoQ) crinetics.com (CRNX)|Choraklik sotuv o'sishi newamsterdampharma.com NAMS|Daromadning choraklik o'sishi (QoQ) Soleno Therapeutics Inc SLNO|Choraklik daromad o'sishi Amicus Therapeutics Inc FOLD|89bio Corp - Choraklik daromad o'sishi|O'tgan chorakka nisbatan daromad o'zgarishi Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Daromadning choraklik o'sishi (QoQ)|Choraklik sotuv o'sishi MiMedx Group, Inc.|Daromadning choraklik o'sishi (QoQ) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Choraklik sotuv ortish sur'ati|Choraklik daromad o'sishi MBX|Choraklik sotuv o'sishi Altimmune, Inc. ALT|Choraklik daromad o'sishi AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Choraklik daromad o'sish sur'ati|BIOA: Choraklik sotuv o'sishi|Choraklik daromad ortishi BMEA (Biomea Fusion)|QNCX (quincetx.com) - Choraklik sotuv o'sishi|Fractyl - Choraklik daromad ortishi|VTVT (vTv Therapeutics Inc) - Choraklik daromad o'sishi|Agape ATP - Daromadning choraklik dinamikasi|Choraklik sotuv o'sishi PLUR (Pluri Inc)|Choraklik sotuv ortish sur'ati Synlogic Inc.|Daromadning choraklik o'sishi (QoQ) Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Choraklik daromad o'sish sur'ati|Spruce Biosciences Inc. - Choraklik daromad o'sishi|Choraklik sotuv ortish sur'ati Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Daromadning choraklik o'sishi (QoQ)|Lumos Pharma - Choraklik daromad ortishi|ONVO (Organovo Corp) - Choraklik daromad o'sishi|Radius Pharmaceuticals (RDUS) - Choraklik sotuv ortish sur'ati